Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
4.690
-0.100 (-2.09%)
At close: Jan 17, 2025, 4:00 PM
4.600
-0.090 (-1.92%)
After-hours: Jan 17, 2025, 7:46 PM EST
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $139.54 million as of January 17, 2025.
Market Cap
139.54M
Enterprise Value
138.80M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.69
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $139.54M, a decrease of -32.68%. That is a compound annual growth rate of -34.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 139.54M | 13.83% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |